Study of Idursulfase-beta (GC1111) in Hunter Syndrome

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
This study evaluates the efficacy and safety of three doses of GC1111 in patients with Hunter Syndrome. Participants will be randomized to one of three doses of GC1111 or comparator.
Epistemonikos ID: 14c5e036d5e3a0882ce470bbdd67e978425a4d3a
First added on: May 12, 2024